Suppression of cytokine synthesis, integrin expression and chronic inflammation by inhibitors of cytosolic phospholipase A 2

Author： Amandi-Burgermeister E.   Tibes U.   Kaiser B.M.   Friebe W.G.   Scheuer W.V.  

Publisher： Elsevier

ISSN： 0014-2999

Source： European Journal of Pharmacology, Vol.326, Iss.2, 1997-05, pp. : 237-250

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Phospholipase A2 inhibitors in inflammation

By Lehr Matthias  

Expert Opinion on Therapeutic Patents, Vol. 11, Iss. 7, 2001-07 ,pp. : 1123-1136

Informa Healthcare

Access to resources Recommend Favorite

Inhibitors of Cytosolic Phospholipase A2 as Potential Anti-Inflammatory Drugs

By  

Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Inflammatory and Anti-Allergy Agents), Vol. 5, Iss. 2, 2006-05 ,pp. : 149-161

Bentham Science Publishers

Access to resources Recommend Favorite

Cytosolic Phospholipase A2 Inhibitors as Therapeutic Agents for Neural Cell Injury

By  

Current Medicinal Chemistry - Anti-Inflammatory & Anti-Allergy Agents, Vol. 1, Iss. 3, 2002-12 ,pp. : 193-204

Bentham Science Publishers

Access to resources Recommend Favorite

Role of Ca 2+ -ATPase inhibitors in activation of cytosolic phospholipase A 2 in human polymorphonuclear neutrophils

By Zhang H.   Garlichs C.D.   Mugge A.   Daniel W.G.  

European Journal of Pharmacology, Vol. 364, Iss. 2, 1999-01 ,pp. : 229-237

Elsevier

Access to resources Recommend Favorite

Activation of nuclear factor- B by lipopolysaccharide in mononuclear leukocytes is prevented by inhibitors of cytosolic phospholipase A 2

By Burgermeister E.   Tibes U.   Stockinger H.   Scheuer W.V.  

European Journal of Pharmacology, Vol. 369, Iss. 3, 1999-03 ,pp. : 373-386

Elsevier

Access to resources Recommend Favorite